Ather­sys files for Chap­ter 11 bank­rupt­cy, sells every­thing to part­ner Healios

Ather­sys has filed for bank­rupt­cy and se­cured a deal to sell off its as­sets to long-stand­ing part­ner and re­gen­er­a­tive med­i­cine com­pa­ny Healios.

The biotech and its four af­fil­i­ates filed for a Chap­ter 11 at the US Bank­rupt­cy Court for the North­ern Dis­trict of Ohio on Jan. 5, ac­cord­ing to a Mon­day SEC fil­ing. Ather­sys’ stock price dropped 33% to close at $0.01 in re­sponse to the news, and it is now delist­ed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER